These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28509578)

  • 1. The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States.
    Rice JB; White AG; Galebach P; Korenblat KM; Wagh A; Lovelace B; Wan GJ; Jamil K
    Curr Med Res Opin; 2017 Aug; 33(8):1473-1480. PubMed ID: 28509578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations.
    Stein EM; Bonifacio G; Latremouille-Viau D; Guerin A; Shi S; Gagnon-Sanschagrin P; Briggs O; Joseph GJ
    J Med Econ; 2018 Jun; 21(6):556-563. PubMed ID: 29304724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.
    Burke JP; Hunsche E; Régulier E; Nagao M; Buzinec P; Drake Iii W
    Am J Manag Care; 2015 Jan; 21(3 Suppl):s47-58. PubMed ID: 25734573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of sarcoidosis in a commercially-insured population in the United States.
    Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
    J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
    Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of venous leg ulcers in the United States.
    Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N
    J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke.
    Johnson BH; Bonafede MM; Watson C
    Clinicoecon Outcomes Res; 2016; 8():53-61. PubMed ID: 26966382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical claim cost impact of improved diabetes control for medicare and commercially insured patients with type 2 diabetes.
    Fitch K; Pyenson BS; Iwasaki K
    J Manag Care Pharm; 2013 Oct; 19(8):609-20, 620a-620d. PubMed ID: 24074007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
    Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
    J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records.
    Jamil K; Huang X; Lovelace B; Pham AT; Lodaya K; Wan G
    J Med Econ; 2019 May; 22(5):421-429. PubMed ID: 30724682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
    Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
    Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers.
    Fitch K; Woolley JM; Engel T; Blumen H
    Am Health Drug Benefits; 2017 Jun; 10(4):202-210. PubMed ID: 28794824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009.
    Dalal AA; Liu F; Riedel AA
    Int J Chron Obstruct Pulmon Dis; 2011; 6():533-42. PubMed ID: 22069365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
    Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
    J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes, Mortality, and Cost Burden of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis.
    Patel A; Zhang C; Minacapelli CD; Gupta K; Catalano C; Li Y; Rustgi VK
    J Gastrointestin Liver Dis; 2023 Mar; 32(1):39-50. PubMed ID: 37004233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US.
    Miloh T; Goldstein A; Howard R; Mogul DB; Marden JR; Anderson A; Gaburo K; Kirson N; Rosenthal P
    Liver Transpl; 2023 Jul; 29(7):735-744. PubMed ID: 36747344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.